Sharon Tetlow's Net Worth
$48.4 Thousand
Who is Sharon Tetlow?
Sharon Tetlow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DICE Therapeutics, Inc., CATALYST BIOSCIENCES, INC., Structure Therapeutics Inc., Ocera Therapeutics, Inc., and CELL GENESYS INC.
SEC CIK
Sharon Tetlow's CIK is 0001328565
Past Insider Trading and Trends
2021 was Sharon Tetlow's most active year for acquiring shares with 5 total transactions. Sharon Tetlow's most active month to acquire stocks was the month of May. 2009 was Sharon Tetlow's most active year for disposing of shares, totalling 9 transactions. Sharon Tetlow's most active month to dispose stocks was the month of September. 2014 saw Sharon Tetlow paying a total of $17,487.00 for 3,000 shares, this is the most they've acquired in one year. In 2008 Sharon Tetlow cashed out on 9,051 shares for a total of $28,103.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DICE Therapeutics, Inc. No price found
InvestorSharon Tetlow used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Sharon Tetlow disposed a total of 49,841 shares of DICE Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.84K |
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CATALYST BIOSCIENCES, INC. (GYRE) Snapshot price: $13.77
InvestorSharon Tetlow owns 3,635 units of Common Stock which is worth $50,053.95. In the year 2020 Sharon Tetlow filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +88.15% | 1.7K |
—
|
—
| 3.63K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 1.93K |
—
|
—
| 1.93K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Structure Therapeutics Inc. (GPCR) Snapshot price: $36.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ocera Therapeutics, Inc. No price found
Acting CFO & TreasurerSharon Tetlow owns 3,000 units of Common Stock. In the year 2014 Sharon Tetlow filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3K |
$5.83 | $17,487.00 | 3K |
Jul 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CELL GENESYS INC No price found
SVP & CFOSharon Tetlow used to own units in Common Stock but no longer holds any shares there. In the year 2005 Sharon Tetlow filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.45K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| -32.91% | -9.05K |
$3.11 | -$28,103.35 | 18.45K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +1,000.00% | 25K |
—
|
—
| 27.5K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
∞
| 2.5K |
$4.91 | $12,275.00 | 2.5K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |